Professor Levitzki is a professor at the Department of Biological Chemistry at the Alexander Silberman Institute of Life Sciences at the Hebrew University in Jerusalem. His work has led to ,
Levitzki’s research has led to understanding of cancer, development of potent anti-cancer drugs and successful therapy in treating leukemia patients. In 1990, he was awarded the Israel Prize in life sciences, and in 2005, he was awarded the Wolf Prize in Medicine for "pioneering signal transduction therapy and for developing tyrosine kinase inhibitors as effective agents against cancer and a range of other diseases".
Read more about Professor Levitzki here.